NSHSF - NanoSphere Health Sciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1807
+0.0095 (+5.56%)
At close: 3:58PM EDT
Stock chart is not supported by your current browser
Previous Close0.1712
Open0.1900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1807 - 0.1900
52 Week Range0.1400 - 0.3900
Volume12,002
Avg. Volume53,606
Market Cap19.249M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0470
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    NanoSphere Health Sciences Announces Retirement of CEO Robert E. Sutton; Dr. Mark Percival Named As Successor

    Mr. Sutton has acted as Chairman and Chief Executive Officer since 2013, after co-founding NanoSphere with Chief Science Officer Dr. Richard Kaufman, and will continue in his role as Chairman of the Board of Directors. “Dr. Percival is the right person to lead NanoSphere into the future,” said Sutton.

  • GlobeNewswire18 days ago

    Colorado Passes Law Allowing Doctors to Prescribe Cannabis in Place of Opioids

    Vancouver, May 29, 2019 -- May 29, 2019:  NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) CEO Robert Sutton today congratulated the Governor and Legislature of.

  • The NanoSphere Health Sciences (CNSX:NSHS) Share Price Is Down 48% So Some Shareholders Are Getting Worried
    Simply Wall St.24 days ago

    The NanoSphere Health Sciences (CNSX:NSHS) Share Price Is Down 48% So Some Shareholders Are Getting Worried

    The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...

  • GlobeNewswirelast month

    NanoSphere Health Sciences and Stat Shield Technology Form Strategic Partnership to Launch Evolve Products for Veterans

    NanoSphere Health Sciences INC (NSHS.CN) (NSHSF), the biotechnology company behind the patented NanoSphere Delivery System™, is pleased to announce that it has signed a Memorandum of Understanding with Stat Shield Technology LLC. A Division of STAT SHIELD ARMOR LLC., where Stat will act as NanoSphere’s exclusive agent for hemp-derived CBD and other products. Stat’s seasoned specialist and trendsetting Divisions covering the Aerospace, Energy, Finance, Aviation, Tier 1 finance- humanitarian programs both Military and Commercial has helped develop programs instrumental in improving business relations with governmental agencies, resulting in company growth and additional employment opportunities. NanoSphere Health Sciences has developed products that successfully leverage the next-generation NanoSphere Delivery System™.

  • GlobeNewswire2 months ago

    NanoSphere and Vertical Unveil the Future of Cannabis at Hall of Flowers Trade Show

    DENVER (DATE)– NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (‘NanoSphere or ‘the Company’) parent company of cannabis brand Evolve Formulas, in partnership with Vertical™, the largest fully integrated company in the legal medical cannabis industry, will formally unveil the Evolve Formulas line for the California market at the Hall of Flowers trade show on April 30. The Hall of Flowers event is a licensed, industry-only, highly curated B2B trade show specifically designed to facilitate the trade of premium licensed cannabis products, including flowers, concentrate, edible, topical, and accessory categories. NanoSphere and its California production and distribution partner The Vertical Companies (Vertical) are inviting all dispensaries and cannabis distributors to join us at the Vertical booth on April 30th for a demonstration of the new product, sold under the Evolve Formulas brand.

  • GlobeNewswire2 months ago

    NanoSphere Health Sciences Has Received Notice of Allowance for a Patent for its Breakthrough Nanoparticle Encapsulations of NSAIDs

    Denver, Colorado, April 24, 2019 -- Biotechnology leader NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF) has received formal Notice of Allowance from the Canadian.

  • GlobeNewswire2 months ago

    NanoSphere Products Approved for Sale in California Cannabis Market

    Vancouver (April 2, 2019)– NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) is pleased to announce its Evolve cannabis products will be available for purchase in California for the first time, after receiving final approval by the State of California. The Evolve Formulas serum will begin shipping to retail outlets next week, said NanoSphere President David Sutton. “This is another major step for our Evolve Formulas line of cannabis products, as we are now moving into the largest legal cannabis market in the world,” Sutton said.

  • NanoSphere Developing Production Lab at Delta 9 Cannabis
    Business Wire3 months ago

    NanoSphere Developing Production Lab at Delta 9 Cannabis

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“NanoSphere” or the Company) is pleased to announce work has begun on the production facility for NanoSphere’s products in Canada, based at the Delta 9 Cannabis Inc. (NINE.V) (VRNDF) facility in Winnipeg, Manitoba. “We’re working hard to get production underway in April, with the goal of getting final approval for the first sales of NanoSphere products before summer,” said NanoSphere CEO Robert Sutton.

  • Business Wire4 months ago

    CORRECTING and REPLACING NanoSphere Closes $2 Million Private Placement Offering

    NanoSphere Health Sciences Inc. (CSE:NSHS) (NSHSF) (“Nanosphere” or “the Company”) is pleased to announce that it has closed its non-brokered private placement announced on Feb. 11, 2019 issuing 6,666,394 units at a price of 30 cents per unit for gross proceeds of $1,999,918.20. Each unit is comprised of one common share and a full purchase warrant exercisable to purchase a further common share at a price of 50 cents for a period of 24 months, subject to accelerated expiry if the Company's shares trade at or above 75 cents for 15 consecutive days. In connection with the closing, the company paid an aggregate of $41,931.41 in finders' fees and issued 106,050 finders' warrants having the same terms as the private placement warrants.

  • Business Wire4 months ago

    NanoSphere Closes $2 Million Private Placement Offering

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“Nanosphere” or “the Company”) is pleased to announce that it has closed its second and final tranche of its non-brokered private placement announced on Feb. 11, 2019. Pursuant to the first tranche, the company issued 6,666,394 units at a price of 30 cents per unit for gross proceeds of $1,999,918.20. Each unit comprises one common share and a full purchase warrant exercisable to purchase a further common share at a price of 50 cents for a period of 24 months, subject to accelerated expiry if the company's shares trade at or above 75 cents for 15 consecutive days.

  • Business Wire4 months ago

    NanoSphere Signs Definitive Licensing Agreement in Oregon

    NanoSphere Health Sciences Inc. (CSE:NSHS) (NSHSF) (“NanoSphere” or “the Company”) is pleased to announce the signing of a definitive Licensing Agreement with Oregon cannabis company Cascade Pure, LLC. The Agreement gives Cascade Pure the exclusive right to produce and distribute Evolve Formulas products in the State of Oregon.

  • Business Wire4 months ago

    NanoSphere Opens $2 million Private Placement Offering

    NanoSphere Health Sciences Inc. (CSE:NSHS) (NSHSF) (“Nanosphere” or “the Company”) is pleased to announce that it will conclude a private placement of up to CAD$2,000,000, which will incorporate the balance of the financing announced on November 16, 2018 as updated December 17, 2018. Each Unit will be comprised of a common share and a full share purchase warrant exercisable to purchase a further common share at a price of $0.50 cents for a period of 24 months, subject to accelerated expiry if the Company’s shares trade at or above $0.75 for 15 consecutive days. Together with this financing, the total gross proceeds raised will be $3.34m (approximately 11,325,250 Units).

  • Business Wire4 months ago

    NanoSphere Receives First Export Order for CBD Hemp Products From Abba Imports in Mexico

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“NanoSphere” or “the Company”) has for the first time received an order to export its patented Evolve Formulas CBD Hemp transdermal NanoSerum™. The initial order is for 60,000 units of the Company’s Evolve Formulas CBD Hemp transdermal NanoSerum™. The order comes from Abba Import Export S.A. de C.V. (Abba), one of the premiere distributors of health and wellness products in Mexico.

  • Business Wire4 months ago

    Game-Changing NanoSphere Products Soon to Disrupt the Oklahoma Cannabis Market

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today signed a new letter of intent with 4Evergrn LLC, which will bring Evolve Formulas products to the Oklahoma medical and recreational cannabis markets. Nanosphere Health Sciences has developed the world’s first patented and clinically-proven delivery system for cannabis.

  • NanoSphere Signs Definitive Licensing Agreement with Delta 9 Cannabis Inc.
    Business Wire5 months ago

    NanoSphere Signs Definitive Licensing Agreement with Delta 9 Cannabis Inc.

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) is pleased to announce the Company has signed a Definitive Master Licensing Agreement (the Agreement) with Delta 9 Cannabis Inc. (NINE.V) (VRNDF) (Delta 9) in a deal that opens the Canadian market to NanoSphere’s patented groundbreaking delivery technology. NanoSphere’s wholly-owned, Canadian-based subsidiary, NanoSphere Cannabis International Inc. (NCI).helped facilitate the agreement and assisted Delta 9 with the first product submission to Health Canada which has now received preliminary approval.

  • Business Wire5 months ago

    Is the Fountain of Youth Found in Nanoparticles?

    NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF) announced today it has developed an anti-aging product combining Hyaluronic Acid (HA) with the Company’s patented Nanosphere Delivery System™. NanoSphere is best known for developing cannabis and CBD products that are delivered via the Company’s patented delivery system. While that enterprise continues to grow, this is NanoSphere’s first product for the cosmeceutical industry.

  • Business Wire5 months ago

    NanoSphere Partners with Gofire to Debut DoseCode-Enabled Products in Colorado Market

    NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today announced the launch of its new, DoseCode-enabled Evolve Formulas products in the Colorado market, leveraging industry-first technology from Denver-based healthcare startup Gofire. The Gofire DoseCode is a branded QR code attached to exclusive plant-based medical products found in hundreds of retailers across Colorado. When patients download the Gofire app, they can use their phones to scan the DoseCode on Evolve Formulas products, allowing them to access and save detailed descriptions, anonymous patient reviews and ratings, complete batch and lab testing information, as well as dosing recommendations from a community of peers who are also seeking relief.

  • Business Wire6 months ago

    NanoSphere Closes $1.335M First Tranche of Private Placement

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce a first tranche closing of its non-brokered private placement announced November 28, 2018. Pursuant to the first tranche, the company issued 4,452,254 Units at a price of $0.30 per Unit for gross proceeds of CAD $1,335,676. In connection with the closing, the company paid an aggregate of $22,636 in finder fees and issued 17,500 finder warrants having the same terms as the private placement warrants.

  • NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico
    Business Wire6 months ago

    NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) (“NanoSphere” or “the Company”), the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce the Company has signed a Letter of Intent forming a partnership with Abba Import Export S.A. de C.V., to launch Evolve’s growing product line in Mexico.

  • Business Wire7 months ago

    NanoSphere Announces Revised Terms for Private Placement

    NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF) announces revised terms for its non-brokered private placement previously announced on Nov. 16, 2018. Each unit will be comprised of a common share and a full purchase warrant exercisable to purchase a further common share at a price of $0.50 cents for a period of 24 months, subject to accelerated expiry if the Company’s shares trade at or above $0.75 for 15 consecutive days. NanoSphere has developed and patented a radically improved delivery system for cannabinoids that allows for precise dosage, faster onset of therapeutic effects, and exponentially higher bioavailability.

  • NanoSphere Develops New Product Eliminating Need to Smoke Cannabis
    Business Wire7 months ago

    NanoSphere Develops New Product Eliminating Need to Smoke Cannabis

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles. The Evolve NanoGel™ uses NanoSphere’s patented delivery system to transport a full spectrum of THC, other cannabinoids and terpenes through the gums and directly to the bloodstream and into cannabinoid receptors. “Oils taken edibly go through the gut where THC is transformed by the liver into a more psychoactive substance called 11-hydroxy-THC (11-OH-THC),” explains Chief Science Officer Dr. Richard Clark Kaufman.

  • NanoSphere Announces $2.25 Million Financing for Rapid Expansion of Cannabis Product Line
    Business Wire7 months ago

    NanoSphere Announces $2.25 Million Financing for Rapid Expansion of Cannabis Product Line

    NanoSphere Health Sciences Inc. (NSHS.CN) (NSHSF) is pleased to announce a non-brokered private placement of up to CAD $2,250,000. “We only received our worldwide patent for our cannabis delivery system in June this year, and already the company is expanding into the US with our Evolve Formulas brand,” said Nanosphere CEO Robert Sutton. Nanosphere has developed and patented a radically improved delivery system for cannabinoids that allows for precise dosage, faster onset of therapeutic effects, and exponentially higher bioavailability.

  • Business Wire7 months ago

    Game-Changing Evolve Formulas Products Soon to Disrupt the Oregon Cannabis Market

    NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today signed a new letter of intent with Cascade Pure, LLC, which will bring Evolve Formulas products to the Oregon medical and recreational cannabis markets. The brand’s pioneering product, the Evolve Formulas Transdermal NanoSerum™, will hit dispensary shelves in the first quarter of 2019.

  • NanoSphere Forms Cannabis Subsidiary in Canada
    Business Wire7 months ago

    NanoSphere Forms Cannabis Subsidiary in Canada

    NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF) (“NanoSphere” or “the Company”), is taking its cannabis business global with the formation of a wholly owned subsidiary, NanoSphere Cannabis International (“NCI”). NanoSphere developed a patented process using nanoparticles to deliver medicines, nutraceuticals and cosmeceuticals directly through the skin or the mucous membrane into the blood stream. The new Vancouver-based company will be charged with the task of licensing NanoSphere’s groundbreaking technology in countries where medical or recreational cannabis is legal.

  • Evolve Formulas Transdermal NanoSerum™ CBD Met with Unprecedented Response across Colorado Market
    Business Wire7 months ago

    Evolve Formulas Transdermal NanoSerum™ CBD Met with Unprecedented Response across Colorado Market

    NanoSphere Health Sciences, Inc. (NSHS.CN) (NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, today announced the expansion of its CBD-dominant product—the Evolve Formulas Transdermal NanoSerum™ CBD with Resveratrol—across Colorado due to considerable public demand. The Evolve Formulas Transdermal NanoSerum™ CBD utilizes a combination formula of synergistic cannabinoids, with each precision-metered dose containing 15mg of CBD and 1.5mg of THC. “NanoSphere takes great pride in developing world-class offerings that not only utilize our cutting edge, patented technology, but that include thoughtful formulations with the consumer in mind.